Investing in Cardiovascular Innovations - What does the future hold?

Session Description

Investments in cardiology devices, including digital health and AI have been in decline over the past 2 years leading many to wonder “what are investors looking for?” In this session, we will explore the current trends of investments in Cardiology, Digital Health and AI and learn from current investors who invest at all stages along the technology life cycle.

Speakers

Stephen Flaim
Senior Special Advisor & Investor-In-Residence | President | Director
National Heart Lung and Blood Institute, NIH | Flaim Partners Consulting | Haima Therapeutics

Daniel Gottlieb
Director of the MedTech Portfolio
Broadview Ventures

David Kim
Managing Director
digiTx Partners

Giovanni Leo
Partner
Lake Geneva Ventures Fund at Efficient Frontier Investing

Charity Tarn
Senior Associate | Board Member | Board Observer
Arboretum Ventures | SonarMD | Motif Neurotech, Reprieve Cardiovascular, Virtual Incision, Avation Medical, and Akadeum Life Sciences

Kathryn Zavala
Chief Operating Officer
MedTech Innovator

Moderator
David Roman
Managing Director in the Global Investment Research Division
Goldman Sachs

Summary


Availability:	On-Demand


Cost:	FREE